AscellaHealth

AscellaHealth, located in Berwyn, Pennsylvania, has established itself as a significant entity in the specialty pharmacy and healthcare services sector with a broad operational footprint across the United States and Europe. The company is dedicated to providing tailored, technology-driven specialty pharmaceutical and medical management services to an array of clients, including payers, providers, life sciences companies, and patients. The company is mainly focused on those suffering from complex chronic conditions or rare diseases, requiring specialty medications and innovative therapies such as gene and cell treatments.

At the helm of AscellaHealth is Dea Belazi, the CEO and Co-founder, whose dual expertise as a registered pharmacist and an experienced business executive has been vital in driving the company's strategic vision and operational success. Under his leadership, the company has grown to employ over 200 professionals and has developed into a globally recognized provider of healthcare and specialty pharmacy solutions. Belazi's guidance is instrumental in developing customized, tech-enabled services that support the successful launch and ongoing commercialization of specialty and rare disease medications, enhancing patient outcomes significantly.

Bill Oldham, who co-founded the company with Belazi, holds the roles of Chairman and President. With a profound background in fintech, Oldham has effectively translated his skills into the pharmacy benefit management (PBM) sector, helping AscellaHealth achieve a leading position in the industry. His leadership has been critical to the company's impressive 1556% revenue growth over four years, driven by both organic growth and strategic acquisitions. Oldham's contributions to the company and the industry have been recognized with several prestigious awards, including Philadelphia Business Journal's 2022 CFO of the Year and repeated recognition in the Philadelphia Titan 100.

AscellaHealth's commitment to improving patient healthcare experiences is evident in its comprehensive service offerings. These include Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, and a Proprietary Specialty Pharmacy and Infusion Network. Advanced technology-based patient engagement tools and thorough medical and pharmacy benefit management systems complement these services.